These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7917701)

  • 41. The use of oral labetalol in the treatment of arrhythmias associated with the long QT syndrome.
    Grubb BP
    Chest; 1991 Dec; 100(6):1724-5. PubMed ID: 1959422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Torsade de Pointes and demand endocavitary pacemaker. A case report].
    Pardo J; Novoa O; González R
    Rev Med Chil; 1998 Dec; 126(12):1503-6. PubMed ID: 10349166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Torsades de pointes associated with acquired long QT syndrome: observation of 7 cases.
    Takahashi N; Ito M; Inoue T; Koumatsu K; Takeshita Y; Tsumabuki S; Tamura M; Inoue K; Maeda T; Saikawa T
    J Cardiol; 1993; 23(1):99-106. PubMed ID: 8164140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug-induced proarrhythmia: Discussion and considerations for clinical practice.
    Klotzbaugh RJ; Martin A; Turner JR
    J Am Assoc Nurse Pract; 2020 Feb; 32(2):128-135. PubMed ID: 32015278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pauses after burst pacing provoke afterdepolarizations and torsades de pointes in a patient with long QT syndrome.
    Kirchhof P; Zellerhoff S; Mönnig G; Schulze-Bahr E
    Heart Rhythm; 2004 Dec; 1(6):720-3. PubMed ID: 15851245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Torsade de pointes--a cause of Morgagni-Adam-Stokes attacks in patients with complete atrioventricular block].
    Antonelli D; Rozner E; Freedberg NA; Turgeman Y
    Harefuah; 2008 Mar; 147(3):204-6, 279. PubMed ID: 18488859
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Perioperative acquired long QT syndrome: a case report].
    Goitia L; Pérez P; Sebastián P; Taibo JM; Arizaga A
    Rev Esp Anestesiol Reanim; 2010 Feb; 57(2):109-14. PubMed ID: 20337003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of torsade de pointes caused by exacerbation of QT prolongation during clipping of cerebral artery aneurysm in a patient with subarachnoid haemorrhage.
    Takenaka I; Aoyama K; Iwagaki T; Ishimura H; Kadoya T
    Br J Anaesth; 2006 Oct; 97(4):533-5. PubMed ID: 16849385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. QT prolongation with torsade de pointes in pheochromocytoma.
    Shimizu K; Miura Y; Meguro Y; Noshiro T; Ohzeki T; Kusakari T; Akama H; Watanabe T; Honma H; Imai Y
    Am Heart J; 1992 Jul; 124(1):235-9. PubMed ID: 1615819
    [No Abstract]   [Full Text] [Related]  

  • 51. The QT interval and torsade de pointes.
    Moss AJ
    Drug Saf; 1999; 21 Suppl 1():5-10; discussion 81-7. PubMed ID: 10597863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unique ECG presentations and clinical management of a symptomatic LQT2 female carrying a novel de novo KCNH2 mutation.
    Yin C; Zhang P; Yang J; Zhang L
    J Electrocardiol; 2018; 51(1):111-116. PubMed ID: 29037423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
    Madias C; Fitzgibbons TP; Alsheikh-Ali AA; Bouchard JL; Kalsmith B; Garlitski AC; Tighe DA; Estes NA; Aurigemma GP; Link MS
    Heart Rhythm; 2011 Apr; 8(4):555-61. PubMed ID: 21146632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of torsade de pointes in the congenital long QT syndrome: use of a pause prevention pacing algorithm.
    Viskin S; Fish R; Roth A; Copperman Y
    Heart; 1998 Apr; 79(4):417-9. PubMed ID: 9616356
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Congenital long QT syndrome: severe torsades de pointes provoked by epinephrine in a digenic mutation carrier.
    Tan VH; Duff H; Kuriachan V; Gerull B
    Heart Lung; 2014; 43(6):541-5. PubMed ID: 25236808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypocalcemic Torsades de Pointes.
    Akiyama T; Batchelder J; Worsman J; Moses HW; Jedlinski M
    J Electrocardiol; 1989 Jan; 22(1):89-92. PubMed ID: 2921582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.
    Glassman AH; Bigger JT
    Am J Psychiatry; 2001 Nov; 158(11):1774-82. PubMed ID: 11691681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Torsades de pointes and prolonged QT syndrome in Takotsubo cardiomyopathy.
    Pacha O; Kadikoy H; Amro M; Haque W; Abdellatif A
    J Cardiovasc Med (Hagerstown); 2012 Aug; 13(8):536-40. PubMed ID: 20075742
    [No Abstract]   [Full Text] [Related]  

  • 59. Sevoflurane-associated torsade de pointes in a patient with congenital long QT syndrome genotype 2.
    Kumakura M; Hara K; Sata T
    J Clin Anesth; 2016 Sep; 33():81-5. PubMed ID: 27555138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long QT syndrome: first and fatal events provoked by hemodialysis.
    Miller RF; Haley MW; Littmann L
    Pacing Clin Electrophysiol; 2003 Jan; 26(1 Pt 1):103-4. PubMed ID: 12685147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.